HD Biosciences Co., Ltd., a wholly owned subsidiary of WuxiAppTec,is a widely recognizedleading biology-focused preclinical drug discovery contract research organization (CRO) with operation facilities in Shanghai, China and San Diego, California, USA. The company offers comprehensive services around target validation, plate-based pharmacology, hit ID & lead discovery, therapeutic antibody discovery, in vivo pharmacology, as well as other R&D activities. The company’s client base include almost all top10 world largest pharmaceutical companies. Through established strategic partnership in many key R&D areas, the company has delivered significant impacts to client’s portfolio. The strong scientific expertise, high quality and consistence in deliveries that meet or exceed client’s expectations, have earned the company a great reputation in the industry.